Galapagos Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Paul Stoffels
Chief executive officer
€2.0m
Total compensation
| CEO salary percentage | 38.0% |
| CEO tenure | 2.6yrs |
| CEO ownership | n/a |
| Management average tenure | 2.5yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -€61m |
| Jun 30 2024 | n/a | n/a | €32m |
| Mar 31 2024 | n/a | n/a | €31m |
| Dec 31 2023 | €2m | €750k | -€4m |
| Sep 30 2023 | n/a | n/a | -€153m |
| Jun 30 2023 | n/a | n/a | -€46m |
| Mar 31 2023 | n/a | n/a | -€69m |
| Dec 31 2022 | €1m | €563k | -€71m |
Compensation vs Market: Paul's total compensation ($USD2.07M) is above average for companies of similar size in the BR market ($USD697.70K).
Compensation vs Earnings: Paul's compensation has increased whilst the company is unprofitable.
CEO
Paul Stoffels (62 yo)
2.6yrs
Tenure
€1,971,286
Compensation
Dr. Paulus A. Stoffels, also known as Paul, Ph.D. M.D. is Chief Executive Officer of Galapagos NV since April 01, 2022 and also serves as its Chairman since April 26, 2022 and also serves as its Interim He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chairman | 2.6yrs | €1.97m | no data | |
| Executive VP | 1.3yrs | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Executive VP & General Counsel | 2.8yrs | no data | no data | |
| Head of Corporate Communication | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | no data | no data | no data | |
| Head of Development | no data | no data | no data | |
| Senior VP & Head of Business Development | 2.8yrs | no data | no data | |
| Head of Medical Affairs | no data | no data | no data | |
| Head of Small Molecules Discovery & Senior VP | 2.4yrs | no data | no data | |
| Head of Strategy & US Lead | 1.1yrs | no data | no data | |
| Head of Clinical Development Oncology | no data | no data | no data |
2.5yrs
Average Tenure
52.5yo
Average Age
Experienced Management: G1LP34's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chairman | 2.6yrs | €1.97m | no data | |
| Independent Non-Executive Director | 1.2yrs | €32.37k | 0.00027% R$ 28.3k | |
| Lead Independent Non-Executive Director | 2.6yrs | €150.00k | 0.0015% R$ 160.3k | |
| Non-Executive Non-Independent Director | less than a year | no data | no data | |
| Non-Executive Non-Independent Director | 5.1yrs | no data | no data | |
| Non-Executive Independent Director | 1.4yrs | €59.85k | 0.00055% R$ 57.6k | |
| Non-Executive Non-Independent Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 5.6yrs | €115.00k | 0.0030% R$ 316.4k | |
| Independent Non-Executive Director | 4.6yrs | €138.75k | 0.0029% R$ 299.6k |
2.6yrs
Average Tenure
62yo
Average Age
Experienced Board: G1LP34's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.